Crown Laboratories (“Crown”), a fully integrated global skincare company, announced today that Nadeem Moiz, Chief Operating Officer and Chief Financial Officer, has been promoted to the position of President in addition to his existing roles. This promotion reflects not only Mr. Moiz’s exceptional leadership, strategic vision, and outstanding performance in his current roles, but also the company’s confidence in his abilities and its commitment to nurturing talent from within the organization.

Mr. Moiz joined Crown in 2022 and has embraced a holistic approach that encompasses strategic planning, operational excellence, financial management, and continuous innovation. As Chief Operating Officer, Mr. Moiz has developed a scalable business model to accommodate growth and has streamlined workflows by optimizing resources to enhance operational efficiency. Simultaneously, as Chief Financial Officer, he has exhibited exemplary leadership in strategic financial management. In this new expanded leadership position, Mr. Moiz will assume broader responsibilities, including setting strategic direction, fostering innovation, and cultivating key partnerships to propel the company to new heights.

“Nadeem has consistently demonstrated an unparalleled dedication to excellence and a remarkable ability to drive our company’s success,” said Jeff Bedard, now Founder/CEO of Crown. “His strategic vision, combined with a deep understanding of operational intricacies and financial dynamics, makes him the ideal candidate to take on this expanded role. I am confident his leadership will continue to propel our company to new heights.”

“As I step into this expanded role of President, I am profoundly honored and energized by the trust placed in me by our company’s leadership,” said Nadeem Moiz. “This promotion represents not only a recognition of my contributions, but also a testament to our collective commitment to driving innovation and excellence in every aspect of our operations. I am excited to leverage my dual expertise in operations and finance to lead our team towards even greater success, delivering value to our stakeholders and making a meaningful impact in the marketplace.”

SOURCEPR Newswire
Previous articleElevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
Next articleHugel begins developing next-generation Type E botulinum toxin